Searched for
NUVAMA TARGET PRICE SUN PHARMA
Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...- Stock Radar: Redington stock breaks out from a downward sloping trendline resistance; time to buy?Redington Ltd. is showing strong bullish signals after breaking a key resistance trendline on weekly charts. Experts suggest short-term tra...
- Carmakers pare discounts as GST cut revives small-car demandCar manufacturers are scaling back discounts on budget-friendly hatchbacks and entry-level models, indicating a robust recovery in mass-mar...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Nifty has more room to run; stay selective: AnalystsIndian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommen...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Missed the FII U-turn? 6 stocks turned multibagger after foreign investors corrected their mistakeForeign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Cons...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Vedanta Power, Oil & Gas, and Iron shares rally up to 5%; Aluminium sheds 3%. Should you buy, sell or hold?Vedanta’s newly demerged entities extended their rally, with Oil & Gas, Power and Iron & Steel hitting upper circuits, while Aluminium slip...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Will Amber Enterprises shares rally in the near term after Oppo deal? Here’s what Nuvama, other brokerages sayAmber Enterprises’ partnership with Oppo has drawn mixed brokerage views, with Nuvama and PL Capital bullish on growth and diversification ...
- Vedanta Power, Aluminium, Oil & Gas and Iron shares soar up to 5%. Which stock looks best placed?Shares of Vedanta’s newly demerged entities rallied up to 5% for a second session, driven by strong investor interest and brokerage optimis...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Buy, Sell or Hold: Goldman Sachs remains neutral on Tata Motors; Nuvama maintains buy on HULBrokerages show selective optimism amidst market jitters. Goldman Sachs backs Shyam Metalics & Energy with a 10% upside target, anticipatin...
- Shares worth $26 billion can soon hit market as IPO lock-ins endApproximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...
- Coforge shares jump over 2% as firm eyes $5 billion revenue by FY30. Why Nomura, others see up to 50% upside?Coforge shares saw a rise after the company projected $5 billion in revenue by FY30. This ambitious target is fueled by strong organic grow...
Load More
